TW200716626A - N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as CCR1 antagonists - Google Patents
N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as CCR1 antagonistsInfo
- Publication number
- TW200716626A TW200716626A TW095121003A TW95121003A TW200716626A TW 200716626 A TW200716626 A TW 200716626A TW 095121003 A TW095121003 A TW 095121003A TW 95121003 A TW95121003 A TW 95121003A TW 200716626 A TW200716626 A TW 200716626A
- Authority
- TW
- Taiwan
- Prior art keywords
- azabicyclo
- oct
- amide derivatives
- ccr1
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200501431A ES2277745B1 (es) | 2005-06-14 | 2005-06-14 | Derivados n-amida de 8-azabiciclo /3.2.1/oct-3-ilo como antagonistas de ccr1. |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200716626A true TW200716626A (en) | 2007-05-01 |
Family
ID=35740673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095121003A TW200716626A (en) | 2005-06-14 | 2006-06-13 | N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as CCR1 antagonists |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090130090A1 (zh) |
EP (1) | EP1891064B1 (zh) |
JP (1) | JP2008543795A (zh) |
CN (1) | CN101228158A (zh) |
AR (1) | AR057651A1 (zh) |
AT (1) | ATE441647T1 (zh) |
DE (1) | DE602006008937D1 (zh) |
ES (2) | ES2277745B1 (zh) |
PE (1) | PE20070017A1 (zh) |
TW (1) | TW200716626A (zh) |
UY (1) | UY29572A1 (zh) |
WO (1) | WO2006133802A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090197914A1 (en) * | 2006-03-07 | 2009-08-06 | Peter Cage | Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
ES2440746T3 (es) | 2008-04-11 | 2014-01-30 | Janssen Pharmaceutica, N.V. | Triazolopiridina-2-iloxi-fenil y triazolopiridina-iloxi-fenil amino como moduladores del leucotrieno A4 hidrolasa |
WO2010091104A1 (en) * | 2009-02-06 | 2010-08-12 | Exelixis, Inc. | Glucosylceramide synthase inhibitors |
CN102459251B (zh) | 2009-05-14 | 2015-05-20 | 詹森药业有限公司 | 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 |
WO2011087812A1 (en) * | 2009-12-21 | 2011-07-21 | Vanderbilt University | Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective m1 agonists and methods of making and using same |
EP2771484A1 (en) | 2011-10-28 | 2014-09-03 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
CN105358551A (zh) * | 2012-07-19 | 2016-02-24 | 詹森药业有限公司 | Ccr2的八氢环戊并吡咯基拮抗剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3633997A (en) * | 1996-07-29 | 1998-02-20 | Banyu Pharmaceutical Co., Ltd. | Chemokine receptor antagonists |
PE20001420A1 (es) * | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
SE0200919D0 (sv) * | 2002-03-25 | 2002-03-25 | Astrazeneca Ab | Chemical compounds |
KR20050028036A (ko) * | 2002-07-18 | 2005-03-21 | 화이자 프로덕츠 인크. | Ccr1 케모카인 수용체의 길항제로서 비시클릭 피페리딘유도체 |
SE0301369D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
-
2005
- 2005-06-14 ES ES200501431A patent/ES2277745B1/es not_active Expired - Fee Related
-
2006
- 2006-05-30 AT AT06753965T patent/ATE441647T1/de not_active IP Right Cessation
- 2006-05-30 JP JP2008516161A patent/JP2008543795A/ja not_active Withdrawn
- 2006-05-30 EP EP06753965A patent/EP1891064B1/en active Active
- 2006-05-30 CN CNA2006800266367A patent/CN101228158A/zh active Pending
- 2006-05-30 DE DE602006008937T patent/DE602006008937D1/de active Active
- 2006-05-30 US US11/921,961 patent/US20090130090A1/en not_active Abandoned
- 2006-05-30 UY UY29572A patent/UY29572A1/es unknown
- 2006-05-30 ES ES06753965T patent/ES2332819T3/es active Active
- 2006-05-30 WO PCT/EP2006/005129 patent/WO2006133802A1/en active Application Filing
- 2006-06-12 PE PE2006000656A patent/PE20070017A1/es not_active Application Discontinuation
- 2006-06-12 AR ARP060102442A patent/AR057651A1/es not_active Application Discontinuation
- 2006-06-13 TW TW095121003A patent/TW200716626A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE441647T1 (de) | 2009-09-15 |
PE20070017A1 (es) | 2007-02-05 |
JP2008543795A (ja) | 2008-12-04 |
EP1891064B1 (en) | 2009-09-02 |
US20090130090A1 (en) | 2009-05-21 |
EP1891064A1 (en) | 2008-02-27 |
WO2006133802A1 (en) | 2006-12-21 |
AR057651A1 (es) | 2007-12-12 |
ES2277745A1 (es) | 2007-07-16 |
DE602006008937D1 (de) | 2009-10-15 |
UY29572A1 (es) | 2006-12-29 |
CN101228158A (zh) | 2008-07-23 |
ES2332819T3 (es) | 2010-02-12 |
ES2277745B1 (es) | 2008-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716626A (en) | N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as CCR1 antagonists | |
EA200801757A1 (ru) | Пиперидинильные производные в качестве модуляторов активности хемокинового рецептора | |
WO2005079497A3 (en) | Substituted fused bicyclic amines as modulators of chemokine receptor activity | |
EP0984965B1 (en) | 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors | |
DE60130562D1 (de) | Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
ATE524466T1 (de) | 3-azabicycloä3.3.0üoktanverbindungen | |
DE602004021921D1 (de) | Azabicycloalkanverbindungen als muscarinrezeptor antagonisten | |
SG154443A1 (en) | Piperidine derivatives as nk1 antagonists | |
WO2005060665A8 (en) | 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors | |
DE602006007556D1 (de) | Heteroarylsulfonylstilbene als 5-ht2a-antagonisten | |
HRP20130614T1 (en) | Novel pyrazole-substituted arylamides | |
WO2005079496A3 (en) | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity | |
WO2005079519A3 (en) | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity | |
TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
ATE449082T1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor | |
PL1615699T3 (pl) | Benzoksazynylo-amidocyklopentylo-heterocykliczne modulatory receptorów chemokin | |
EA200500172A1 (ru) | Азабициклопроизводные в качестве антагонистов мускариновых рецепторов | |
SG175130A1 (en) | Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof | |
EA200701345A1 (ru) | Производные триазолона, тетразолона и имидазолона для применения в качестве антагонистов альфа-2с-адренорецептора | |
HRP20100726T1 (hr) | Triciklički spojevi i njihova upotreba kao modulatora glukokortikoidnih receptora | |
WO2009015164A3 (en) | Piperidinyl derivatives as modulators of chemokine receptor activity | |
CL2008000904A1 (es) | Compuestos derivados de azabiciclo [3.3.0]octenos y azabiciclo[3.3.1]nonanos sustituidos, con la alta afinidad a receptores nicotinicos de subtipo alfa4beta2 en el sistema nervioso central; composicion farmaceutica; y su uso en el tratamiento del deterioro de la memorias asociado a la edad, deterioro cognitivo leve, demencia senil, entre otras. | |
WO2006134486A3 (en) | Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists | |
EP1988075A4 (en) | PYRROLE DERIVATIVE OR SALT THEREOF | |
MY142557A (en) | Compact pot tending module for use in plants for the production of aluminium by electrolysis |